Show Filters

Searches all publications.

Search Fulltext



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-03-22
    E.g., 2018-03-22


64 items
8:21 AM, Dec 22, 2016  |  BC Innovations | Finance

Starting up stem cells

In launching BlueRock Therapeutics with a $225 million series A round, comprehensive IP portfolio and set of strategic partnerships, Versant Ventures and Bayer AG are sending a message they are not only ready to go...
5:50 AM, Dec 14, 2016  |  BC Innovations | Finance

Politicizing science

While the FDA reform provisions in the 21st Century Cures Act give the agency backing to carefully advance some of its long-term objectives, an analysis of the bill’s details suggests that when it comes to...
12:00 AM, Oct 20, 2016  |  BC Innovations | Finance

3Q16 Public-Private Partnership Roundup

  Formation of new PPPs cooled off considerably this summer after a blistering pace in 2Q16, with the fewest preclinical research-oriented partnerships since 3Q14. Only 37 partnerships were recorded by BioCentury in 3Q16, a nearly 50%...
12:00 AM, Oct 06, 2016  |  BC Innovations | Finance

X-ing out resistance

Government, charity and academic organizations in the U.S. and U.K. are teaming up to bridge the translational valley of death for new products to battle antimicrobial resistance with Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X),...
12:00 AM, Aug 04, 2016  |  BC Innovations | Finance

2Q16 Public-Private Partnership Roundup

A new consortia revival helped boost public-private partnerships (PPPs) in 2Q16 to the highest total in two years. Newly announced preclinically focused deals jumped 30% over the relatively sluggish first quarter, from 56 PPPs to...
12:00 AM, Jul 28, 2016  |  BC Innovations | Finance

MRCT looks east

MRC Technology (MRCT) is broadening its reach to Asia with a new strategy that extends beyond the source and geography of its original mission to serve as the tech transfer arm of the U.K.'s Medical...
12:00 AM, Jun 30, 2016  |  BC Innovations | Finance

It takes M2

Mark Zipkin, Staff Writer  Two Melbourne-based universities are creating an independent investment vehicle to boost basic research coming out of local labs and build a translational ecosystem in southeastern Australia and beyond. While the enterprise, M2...
12:00 AM, May 19, 2016  |  BC Innovations | Finance

Found in translation

Mark Zipkin, Staff Writer  With almost $1 billion in new venture funds in the last year and a half aimed at academic research, Europe is showing signs of a dedicated effort among investors and universities alike...
12:00 AM, Apr 28, 2016  |  BC Innovations | Finance

Virtually biotechs

Harvard University's $20 million licensing deal with Merck & Co. Inc in March for a preclinical cancer therapy brought in more cash in one swoop than the university's tech transfer office saw in all of...
12:00 AM, Apr 28, 2016  |  BC Innovations | Finance

Bridging translation

An increasing number of academic institutions are filling the translational gap between what typical academic projects produce and what companies or VC firms want to see in order to commercialize a discovery. These organizations, or...